[Sometimes -- I just need to rant. Forgive me for that. I'll try to be. . . restrained, here.]
At the end of last month, Fast Fred Hassan was added to the board of directors of Amgen -- a fine (and storied) biotech company.
This led some in the MSM to speculate that Amgen may be a target -- given Fred's history.
I will make no comment on that score -- or any other.
All I can offer is. . . my condolences -- to the affected shareholders. Onward, now -- to the northlands!
No comments:
Post a Comment